why choose us

First received: August 19, 2022

Clinical Trial: Study of SGR-1505 in Mature B-Cell Neoplasms

Study Status: Completed

Recruit Status: RECRUITING

Condition: Mature B-Cell Neoplasm

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-Label, Multicenter, Dose Escalation Study of SGR-1505 as Monotherapy in Subjects With Mature B-Cell Malignancies

Brief Summary: The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) and/or recommended dose (RD) of SGR-1505.

Read more